| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Andrology, Vol 16, Issue 2 97-99, Copyright © 1995 by The American Society of Andrology
REVIEW |
C. Y. Young, P. E. Andrews and D. J. Tindall
Department of Urology, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA.
In vitro studies suggest that the protease activity of PSA might play a functional role to facilitate the growth and spreading of cancerous prostatic cells. hK2 may have similar properties. Further investigation to prove their in vivo effects is required. Regulation of PSA and hKLK2 gene expression is mediated not only by androgens, but also by a number of autocrine and paracrine factors, suggesting that the control mechanisms for expression of these genes are complex and multifaceted. Such factors may also be integral for the growth and differentiation of prostate cells. Thus PSA and hKLK2 may serve as useful markers to study the regulation of gene expression during cell growth and differentiation of the prostate.
This article has been cited by other articles:
 |
|
 |
|
  H. Yoon, G. Laxmikanthan, J. Lee, S. I. Blaber, A. Rodriguez, J. M. Kogot, I. A. Scarisbrick, and M. Blaber Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases J. Biol. Chem., November 2, 2007; 282(44): 31852 - 31864. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Borgono, I. P. Michael, and E. P. Diamandis Human Tissue Kallikreins: Physiologic Roles and Applications in Cancer Mol. Cancer Res., May 1, 2004; 2(5): 257 - 280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. K. Bera, R. Maitra, C. Iavarone, G. Salvatore, V. Kumar, J. J. Vincent, B. K. Sathyanarayana, P. Duray, B. K. Lee, and I. Pastan PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach PNAS, March 5, 2002; 99(5): 3058 - 3063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Meng, A. Shan, L. Jin, and C. Y. F. Young The Expression of a Variant Prostate-specific Antigen in Human Prostate Cancer Epidemiol. Biomarkers Prev., March 1, 2002; 11(3): 305 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. Yousef and E. P. Diamandis The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease Endocr. Rev., April 1, 2001; 22(2): 184 - 204. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Spitzweg, M. K. O’Connor, E. R. Bergert, D. J. Tindall, C. Y. F. Young, and J. C. Morris Treatment of Prostate Cancer by Radioiodine Therapy after Tissue-specific Expression of the Sodium Iodide Symporter Cancer Res., November 1, 2000; 60(22): 6526 - 6530. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. W. Gregory, D. Kim, P. Ye, A. J. D’Ercole, T. G. Pretlow, J. L. Mohler, and F. S. French Androgen Receptor Up-Regulates Insulin-Like Growth Factor Binding Protein-5 (IGFBP-5) Expression in a Human Prostate Cancer Xenograft Endocrinology, May 1, 1999; 140(5): 2372 - 2381. [Abstract] [Full Text]
|
|
|
|
|
|
C. Spitzweg, S. Zhang, E. R. Bergert, M. R. Castro, B. McIver, A. E. Heufelder, D. J. Tindall, C. Y. F. Young, and J. C. Morris Prostate-specific Antigen (PSA) Promoter-driven Androgen-inducible Expression of Sodium Iodide Symporter in Prostate Cancer Cell Lines Cancer Res., May 1, 1999; 59(9): 2136 - 2141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.-C. Yu, G. T. Sakamoto, and D. R. Henderson Identification of the Transcriptional Regulatory Sequences of Human Kallikrein 2 and Their Use in the Construction of Calydon Virus 764, an Attenuated Replication Competent Adenovirus for Prostate Cancer Therapy Cancer Res., April 1, 1999; 59(7): 1498 - 1504. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
